iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Burns J W & Co. Inc. NY

Burns J W & Co. Inc. NY lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 19,519 shares of the financial services provider’s stock after selling 129 shares during the period. Burns J W & Co. Inc. NY’s holdings in iShares Biotechnology ETF were worth $2,581,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Security National Bank of SO Dak raised its stake in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. raised its position in shares of iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management lifted its stake in shares of iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after acquiring an additional 76 shares during the period. Capital Investment Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. increased its stake in shares of iShares Biotechnology ETF by 6.0% during the second quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB traded up $1.29 during midday trading on Monday, hitting $134.02. 1,434,925 shares of the stock were exchanged, compared to its average volume of 1,451,048. The business has a 50-day moving average price of $137.95 and a two-hundred day moving average price of $141.99. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.